Combined Angiography Market: Global industry analysis & forecast

0
1393
pharmacy

Angiography is an X-ray imaging technique in which, contrasting agents are injected into the blood stream to visualize the blood vessels and help understand the abnormalities of blood vessels such as aneurysms and atherosclerosis. It is commonly used for diagnosing the heart diseases such as Coronary artery diseases. According to WHO, in 2012, 17.2 million people have died from cardiovascular diseases globally. Among them, 42.2% of the population were victims of the coronary artery disease.

Computed Tomography (CT), angiography, and Magnetic Resonance Imaging (MRI) angiography are new angiography techniques that are used to diagnose abnormalities in bloodvessels. These procedures are can heal comparatively faster than conventional X-ray angiography technique (digital subtraction angiography). However, in this procedure, only abnormalities in blood vessels are diagnosed whereas conventional angiography helps in diagnosing abnormalities and treating blocked arteries.

READ
WWCVL Rebrands Logo, Now Known as ‘Worldwide Healthcare’

Hence, in recent years angiographic imaging system vendors have developed combined angiography device systems, which have both DSA and CT scan to treat and diagnose the blood vessel abnormalities. These devices are present in two different operating rooms to diagnose and treat the blood vessel diseases due to which, most of the time is often lost in transferring the patients from the CT room (Diagnosis) to angio room (Treatment). Hence, combined angiography system plays an
important role in treating and diagnosing the patient in same operating room and reduces space for the equipment.
These systems have a new 3D-application which links the angiography systems with CT images previously taken during the interventional process. Hence, the systems provide exceptional imaging qualities and makes it easier for surgeons to conduct surgeries. Few companies have developed mobile platforms to enable the multidisciplinary teams perform the procedures comfortably without any obligatory access to patients. In addition to these, systems will provide precision dosing, which expose the patient to less radiation as compared with the conventional system.

READ
Nigerian Pharma Industry on Path to Global Reckoning, Says Adigwe

These systems have multiple-utility application areas, rising incidence of cardiac diseases, adaptation to new technologies and increasing awareness about the disease are the major factors driving the growth of combined angiography market. Complex regulatory process and the high cost of these These new angiography systems are expected to boost the market growth during the forecast period. The angiography system will have both X-ray and CT scan which enables the doctor to choose appropriate scan to diagnose the disease. Furthermore these devices help in delivering of precision dose and surgeries can be performed in the single operating room. In addition to that, these systems can provide 3D/4D image visualization during the surgery process.

READ
SPER 2017 International Conference & Exhibition on “Nurturing Pharmaceutical Sciences”

View Full Report@ http://www.persistencemarketresearch.com/market-research/combinedangiography-market.asp

Request for Table of Content@ http://www.persistencemarketresearch.com/toc/11884
The product type is segmented into five categories – Discovery IGS system, MIYABI Angio-CT, Trinias
series MiX Package, INFX-8000C + CT (Aquilion), and Allura Clarity. GE Health Care, Discovery IGS
system, is expected to have a large market share in USA because it recently got FDA approval in
USA.

LEAVE A REPLY

Please enter your comment!
Please enter your name here